Evaluating the mucolytic effectiveness of Ambroxol and N-Acetylcysteine in patients with Acute exacerbation of chronic obstructive pulmonary disease
Introduction: Chronic obstructive pulmonary disease (COPD) is the third most fatal disease globally. Acute deterioration of the patient's respiratory symptoms is known as an acute exacerbation of COPD (AECOPD), that goes beyond usual variations and result in change in medications. Ambroxol (ABX...
Saved in:
| Main Authors: | Aswin A. Anil, Devendu Rajesh, Aishwarya Laxmi Krishnan, Ciciliya Arun, Rosemary Thomas, Prashant Chandra, Nithya Haridas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Clinical Epidemiology and Global Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213398424002860 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANALYSIS OF QUALITY INDICATORS AND PARAMETRS OF SYRUP AMBROXOL PRODUCTION USING STATISTICAL METHODS
by: S. N. Egorova, et al.
Published: (2019-01-01) -
Synergistic action of mucoactive drugs and phages against Pseudomonas aeruginosa and Klebsiella pneumoniae
by: Bingrui Sui, et al.
Published: (2025-03-01) -
Cardiac Dysfunction Indices and Their Prognostic Value in Acute Exacerbation COPD Patients
by: Ahmad B. Elden, et al.
Published: (2020-01-01) -
Efficacy and safety of inhaled ambroxol solution in improving sputum of lower respiratory tract infection in children: a multicenter, randomized, double-blind, placebo-controlled trial
by: Baoping Xu, et al.
Published: (2025-08-01) -
Cost-effectiveness analysis of ambroxol for the treatment of Chinese patients with Gaucher disease
by: Yueyang Huang, et al.
Published: (2025-05-01)